Product Information
ERYTHROMYCIN 200 MG/5 ML SUSP is a generic product labeled by Wilshire Pharmaceuticals Inc., priced at $1.6022 per ML under NDC 52536013613. Its NADAC has been published 167 times since Sep 23, 2020.
Strength
200 mg/5mL
Manufacturer
Wilshire Pharmaceuticals Inc.NDC
52536013613
Classification
Generic
Dosage Form
GRANULE, FOR SUSPENSION
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ERYTHROMYCIN ETHYLSUCCINATEApproval Type
New Drug (NDA)
FDA Application
NDA050207On Market Since
9/28/2016
Pharmacological Classes
Price Statistics
The NADAC for ERYTHROMYCIN 200 MG/5 ML SUSP has been published 167 times since Sep 23, 2020, and over the history we have for it it has declined 37.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.6022 per ML |
|---|---|
| All-time high | $2.5796 (Sep 15, 2021) |
| All-time low | $1.1184 (Nov 20, 2024) |
| 52-week high | $1.6022 |
| 52-week low | $1.2528 |
| Median price | $1.4684 |
| Average price | $1.7404 |
| Largest weekly change | -51.8% (Apr 17, 2024) |
| Weeks tracked | 167 |
| Tracking since | Sep 23, 2020 |
Generic Alternatives
The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 44% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ERYTHROMYCIN 200 MG/5 ML SUSP?
The current National Average Drug Acquisition Cost (NADAC) for ERYTHROMYCIN 200 MG/5 ML SUSP, manufactured by Wilshire Pharmaceuticals Inc., is $1.6022 per ML (NDC 52536013613), effective Jun 24, 2026.
How has the price of ERYTHROMYCIN 200 MG/5 ML SUSP changed over time?
Over the history we have for it, the NADAC for ERYTHROMYCIN 200 MG/5 ML SUSP has declined 37.9%. It has been tracked across 167 weekly CMS publications since Sep 23, 2020.
What are the highest and lowest recorded NADAC prices for ERYTHROMYCIN 200 MG/5 ML SUSP?
Since Sep 23, 2020, the NADAC for ERYTHROMYCIN 200 MG/5 ML SUSP has ranged from a low of $1.1184 (Nov 20, 2024) to a high of $2.5796 (Sep 15, 2021), with a median of $1.4684 per ML.
Are there cheaper alternatives to ERYTHROMYCIN 200 MG/5 ML SUSP?
Yes. 5 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, ERYTHROMYCIN 200 MG/5 ML SUSP, is $0.9048 per ML — about 44% below ERYTHROMYCIN 200 MG/5 ML SUSP.
Who manufactures ERYTHROMYCIN 200 MG/5 ML SUSP?
ERYTHROMYCIN 200 MG/5 ML SUSP (NDC 52536013613) is labeled by Wilshire Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification